June 6, 2022
A stress protein that is overactive in many types of tumor cells also has a key role in tumor-supporting cells called fibroblasts, and may be a good target for future cancer treatments, suggests a new study.
Stress protein in fibroblasts may be a good target for future cancer drugs
June 3, 2022
Inflammatory bowel disease is accompanied by a number of changes in the intestines, such as a change in epithelial permeability, a change in the composition of the microorganisms, and altered levels of antimicrobial substances that are secreted by cells lining the gut. Finding out whether changes are a cause or an effect of the inflammation is difficult. Microbiologists have now teased out the causal chain leading to inflammation.
Fecal transplant throws new light on inflammatory bowel disease
June 3, 2022
A new study has found that RAAS inhibitors, a class of blood pressure-lowering medicine, may be better at reducing the risk of brain aneurysm rupture. People with a brain aneurysm -- a weakened area of a blood vessel -- who were being treated for high blood pressure with medication from the class of drugs called RAAS inhibitors had a significantly lower risk of a ruptured aneurysm compared to those who took other blood pressure medications. These results indicate that RAAS inhibitors may be preferable to other blood pressure-lowering medications and could inform treatment decisions for people with high blood pressure who have unruptured intracranial aneurysms.
June 3, 2022
A new study shows that among adults with obesity, weight loss achieved with bariatric surgery was associated with a 32% lower risk of developing cancer and a 48% lower risk of cancer-related death compared with adults who did not have the surgery.
Weight loss with bariatric surgery cuts the risk of developing cancer and death from cancer
June 3, 2022
Pandemic-era changes to prescribing guidelines for the lifesaving drug buprenorphine led to improved treatment outcomes for patients with opioid use disorder in Philadelphia, according to a recently published study.
Removing barriers to opioid use disorder treatment shows success during pandemic
June 3, 2022
New results from a study in Kenya add to growing evidence that a single dose of human papillomavirus (HPV) vaccine is highly effective in protecting young women against cervical infection with cancer-causing HPV types.
More Evidence that One HPV Vaccine Dose Protects against Cancer-Causing Infections
June 2, 2022
Human Resources is reminding faculty and staff that the University provides multiple resources to assist expecting parents as well as breastfeeding mothers after they have returned to work. Available resources support the physical health, behavioral health, financial wellness and work-life integration pillars of the Healthy Boiler Program.
Support provided for expecting parents, breastfeeding mothers
June 2, 2022
Your diet and your colon have an intimate relationship. Molecules broken down from food and drink continuously bathe the cells that line the intestines. It’s these cells, called epithelial cells, that give rise to the most common type of colorectal cancer. This relationship has sparked decades of research into diet and colorectal cancer risk. In a new study in mice, researchers have found evidence that a compound produced while eating a ketogenic diet—that is, a diet very high in fat and low in carbohydrates—could inhibit the development of colorectal cancer. The compound, called ?-hydroxybutyrate (BHB), jump-started a signaling pathway in epithelial cells in the colon that instructed them to stop dividing.
June 2, 2022
A new study shows that counting cancerous lymph nodes could be a reliable outcome predictor for cancer patients.
Counting cancerous lymph nodes is best predictor of mortality across most cancers
June 2, 2022
Mechanisms associated with a particular diabetes drug can also help to protect against Alzheimer's disease, a new study reports. The results indicate that the drug's target protein can be an interesting candidate for the treatment of Alzheimer's disease.
Target protein for diabetes drug linked to reduced risk of Alzheimer's disease
